Our Gene Writing™ technology positions us to advance genetic medicine beyond its current limitations.
We are developing a broad toolkit of Gene Writers designed to make nearly any type of genomic alteration needed to treat or cure disease. Our technology has the potential to target single point mutations, insertions and deletions, and insert exon or gene-length sequences.
Rewriting (Short Edits)
Substituting single nucleotides or small segments of DNA, including the precise correction of insertion or deletion mutations
Writing Exons (Exon-length Insertions)
Writing exon-length sequences with single nucleotide precision
Writing Whole Genes (Gene-length Insertions)
Adding entire genes into the genome to restore function or deliver new instructions
We use Gene Writers™ to write DNA in the genome
Gene Writers designed to enable the full spectrum of genome editing outcomes.
Gene Writers are designed to be modular to make a wide range of genomic alterations, enabling writing of long messages in the human genome as well as rewriting of short DNA sequences such as single base pair changes to correct disease-causing mutations.
Retrotransposons permanently write DNA using RNA as a template through a process known as target-primed reverse transcription, or TPRT. Four functional subunits catalyze TPRT by binding to an RNA template, binding a target DNA site in the genome, nicking this DNA, and reverse transcribing the new template into the target site.
Gene Writers are designed to efficiently insert a small sequence of DNA, down to a single letter of code, where existing DNA needs to be corrected or adjusted to achieve a therapeutic benefit.
Gene Writers are designed to replace an entire exon with single nucleotide level specificity to offer therapeutic corrections for mutations within these coding regions.
Gene Writers are designed to insert a large sequence of DNA such as a gene into the genome.